Skip to main content
. 2016 Aug 31;12(4):2778–2782. doi: 10.3892/etm.2016.3638

Figure 1.

Figure 1.

Effects of OPG and receptor activator of nuclear factor κβ ligand/OPG on SW1353 cell viability. Cells were treated with 200 ng/ml OPG at various concentrations of receptor activator of nuclear factor κβ ligand (1.25–80 ng/ml), for 24 h. Data are expressed as the mean ± standard deviation. OPG, osteoprotegerin, IL-1β, interleukin-1β.